Table 1

Characteristics of patients between patients with/without nephrotic syndrome

	Nephrotic syndrome				P values
	Yes		No
	(n=3663)		(n=14 652)
	n	%	n	%
Age, year					0.99
20–49	1890	51.6	7560	51.6
50–64	1043	28.5	4172	28.5
≥65	730	19.9	2920	19.9
Mean (SD)*	50.2	15.8	49.7	16.0	0.14
Gender					0.99
Female	1525	41.6	6100	41.6
Male	2138	58.4	8552	58.4
Comorbidity
Diabetes	472	12.9	980	6.69	<0.001
Hypertension	1251	34.2	3625	24.7	<0.001
Hyperlipidaemia	1057	28.9	2305	15.7	<0.001
Coronary artery disease	636	17.4	1742	11.9	<0.001
Head injury	117	3.19	368	2.51	0.02
COPD	449	12.3	1259	8.59	<0.001
Depression	190	5.19	531	3.62	<0.001
Stroke	89	2.43	429	2.93	0.10
Dementia	37	1.01	147	1.00	0.97
Epilepsy	31	0.85	96	0.66	0.21
Medication
Immunosuppressant therapies	95	2.59	138	0.94	<0.001
Biological therapy rituximab with prednisolone†	2	0.05	6	0.04	0.66